Immix Biopharma (IMMX) Interest & Investment Income (2023 - 2026)
Immix Biopharma's Interest & Investment Income came in at $913,663 for Q2 2026, up 778.0% from $104,056 a year earlier and up 27.4% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Immix Biopharma reported Interest & Investment Income of $1.93 million, up 177.3% year-over-year; for FY2025, it was $555,526, down 45.4% from FY2024.
- Going back by year, Interest & Investment Income was $1.02 million in FY2024 (+77.9%) and $572,006 in FY2023.
- The Q2 2026 figure represents the highest quarterly Interest & Investment Income in data going back to Q1 2023.
- Year-over-year, Interest & Investment Income has increased for three consecutive quarters, with growth averaging 126.7% over the last eight quarters.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q1 2024 (growth of 860.5%), and the weakest in Q3 2025 (a decline of 67.1%).
- Business Quant data shows IMMX's Interest & Investment Income at $717,168 (Q1 2026), $216,712 (Q4 2025) and $84,539 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Immix Biopharma | 692.47 Mn | 692.47 Mn | - | 913,663.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 913,663.00 |
| Mar 31, 2026 | 717,168.00 |
| Dec 31, 2025 | 216,712.00 |
| Sep 30, 2025 | 84,539.00 |
| Jun 30, 2025 | 104,056.00 |
| Mar 31, 2025 | 150,219.00 |
| Dec 31, 2024 | 185,851.00 |
| Sep 30, 2024 | 256,680.00 |
| Jun 30, 2024 | 306,915.00 |
| Mar 31, 2024 | 267,908.00 |
| Dec 31, 2023 | 228,575.00 |
| Sep 30, 2023 | 186,691.00 |
| Jun 30, 2023 | 128,848.00 |
| Mar 31, 2023 | 27,892.00 |
API Access
Immix Biopharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();